Pancreatic Cancer Research

ResearcherSecond Military Medical UniversityNo recent work listed

Ling Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1206-7213; OpenAlex author ID A5091089453. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper

Papers 2

  1. Autologous ex vivo expanded NK cells combined with PD-1 inhibitor improved ascitic fluid immune microenvironment of peritoneal metastatic pancreatic cancer: a … Co-author PMID 36777837↗
  2. Application of natural killer cells in pancreatic cancer. First author DOI 10.3892/ol.2021.12908↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaobo Peng · 2 shared papers, 2021–2023 · strength 0.34
  2. Xianbao Zhan · 2 shared papers, 2021–2023 · strength 0.34
  3. Yanfang Liu · 1 shared paper, 2023 · strength 0.18
  4. Meng Guo · 1 shared paper, 2023 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.